Great work Saltee. The Glasgow one would have been great for me but people who have had chemo are excluded and that counts me out unfortunately. Our secondary trials up here are very limited unfortunately.
Thank you saltee, I was hoping that you would come on this website with the trials details as I don't know how to copy them in here **hangs head in shame....** 😞😞 There are many posters who may be interested and often their Oncs don't seem to know about them!! xx
Study of AZD2014 (an mTor inhibitor) and Palbociclib in Patients With Estrogen Receptor Positive (ER+) Metastatic Breast Cancer (PASTOR)
Not recruiting in the UK yet
Palbociclib in Molecularly Characterized ER-positive/HER2-negative Metastatic Breast Cancer (PYTHIA)
Study to Evaluate the Efficacy and Safety of Palbociclib in Combination With Fulvestrant or Letrozole in Patients With ER+, HER2- Locally Advanced or Metastatic Breast Cancer (PARSIFAL)
PIPA: Combination of PI3 Kinase Inhibitors and PAlbociclib (PIPA)
Study of LEE011 (=ribociclib), BYL719 (=Alpelisib) and Letrozole in Advanced ER+ Breast Cancer
There has been a lot of interest in accessing Palbociclib/Ibrance through trials since NICE refused to fund it in the UK. Given the context, I thought a thread linking to trials might be useful. I will kick off with the trials I have heard about. Please add to the list so that others can benefit.
I am including Ribociclib trials as it is a similar agent.
Note many of these are international trials but include UK locations.
PS You can search for trials yourselves here: